Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study
MENOK
Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control
MENOK
Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control
Sponsor study identifier
observational
230
2 countries
5
Study Start
March 21, 2023
Actual (reported)Primary Completion
June 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 21, 2023
Actual (reported)October 30, 2023
Actual (reported)November 7, 2023
Actual (reported)June 30, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Near viewing duration
Duration during near tasks
12 months
Near viewing distance
Distance during near tasks
12 months
Outdoor time
Ambient illumination to determine time spent outdoors
12 months
Objective cycloplegic central refraction
12 months
Axial length
12 months
Subjective cycloplegic central refraction
12 months
The Vivior is a wearable clip-on sensor that objectively quantifies near viewing distance and duration, and ambient illumination. The Vivior will be attached to the spectacles frame of children undergoing myopia control treatment.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Myopic children will be recruited from the university based myopia control clinic. Some clinical sites have collaborated with community optometry practices so support recruitment.
School of Optometry, University of California, Berkeley
Berkeley, California, 94720, United States
New England College of Optometry
Boston, Massachusetts, 02115, United States
State University of New York (SUNY), College of Optometry
New York, New York, 10036, United States
First Submitted
October 30, 2023
First Posted
November 7, 2023
Study Start
March 21, 2023
Actual (reported)Primary Completion
June 30, 2026
Estimated (date passed)Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
Contact the study team to confirm eligibility.
School of Optometry and Vision Science, UNSW
Sydney, New South Wales, 2052, Australia
Optometry and Vision Science, Queensland University of Technology
Kelvin Grove, Queensland, 4059, Australia
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
December 12, 2024
Record last verified: 2024-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: